Article
Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening - Nature Biomedical Engineering
Rating:
0.0
Views:
47
Likes:
1
Library:
1
Developing therapeutic antibodies is laborious and costly. Here we report a method for antibody discovery that leverages the Illumina HiSeq platform to, within 3 days, screen in the order of 108 antibody–antigen interactions.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value